公司资料
Veeva 股价、新闻与催化剂
- 股票代码:
- VEEV
- 交易所:
- NYSE
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
281.93 USD (-1.23%)
收盘价
最后更新: 2026年10月1日
29.9B USD
市值
股价为何变动
截至 2026年10月1日，VEEV 下跌 1.23%，收于 $281.93。当前新闻监测窗口内未发现新的同公司新闻。
公司概览
Life Sciences Industry Cloud Company
Veeva Systems provides cloud applications, data products, artificial intelligence agents, and consulting services purpose-built for life sciences. Its customers range from emerging biotechnology companies to the world's largest pharmaceutical manufacturers.
Commercial Cloud
Veeva Commercial Cloud includes Vault CRM, content, data, analytics, and customer-engagement applications used by sales, marketing, and medical teams. The suite supports regulated interactions with healthcare professionals and coordinated product commercialization.
Development and Quality Cloud
Development Cloud and Quality Cloud support clinical operations, regulatory information, safety, quality management, training, and manufacturing documentation. These applications create a connected foundation for managing regulated content and processes across the product lifecycle.
Data and Consulting Services
Veeva combines software with reference data, patient and prescriber data products, and consulting. This integrated model helps customers implement common data standards and execute commercial and development programs on the same industry-specific platform.
AI Agents and Falcon Platform
Veeva is embedding standard and configurable agents into Vault applications while developing Falcon as an agentic labor platform for clinical, regulatory, and safety work. The strategy applies AI within governed life-sciences workflows rather than offering a general-purpose horizontal tool.
未来催化剂
- Initial customer go-lives for the Veeva Falcon agentic labor platform by year-end 2026.
近期新闻
新闻标题由机器翻译，详情为英文原文。
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。